Ironwood Announces FDA Advisory Committee Meeting Will Not Be Scheduled in Connection with New Drug Application for ...
Ironwood Pharmaceuticals, Inc. announced that it was informed this evening that the U.S. Food and Drug Administration will not schedule an advisory committee meeting in connection with the its review of the New Drug Application for linaclotide proposed for the treatment of irritable bowel syndrome with constipation and chronic constipation .

Press Release
Ironwood Pharmaceuticals Inc. Posted on:09 Feb 12 Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced that it was informed this evening that the U.S. Food and Drug Administration (FDA) will not schedule an advisory committee meeting in connection with the its review of the New Drug Application (NDA) for linaclotide proposed for the treatment of irritable bowel syndrome with constipation (IBS ...

Ironwood Pharmaceuticals Prices Public Offering of Common Stock
Ironwood Pharmaceuticals, Inc. announced today the pricing of an underwritten public offering of 5,250,000 shares of its Class A common stock at a price of $15.09 per share to the public.

Lubiprostone Meets Primary Endpoint in Phase 3 Clinical Trial for Opioid-Induced Bowel Dysfunction (OBD)
Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals U.S.A., Inc. announced today that lubiprostone met the primary endpoint in a phase 3 clinical trial fo

Ironwood Pharmaceuticals Announces Proposed Public Offering of Common Stock
Ironwood Pharmaceuticals, Inc. announced today that it has commenced an underwritten public offering of 5,250,000 shares of its Class A common stock. All of the shares are being offered by Ironwood.

Pain Therapeutics - Drugs, Markets and Companies
NEW YORK, Feb. 1, 2012  /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Pain Therapeutics - Drugs, Markets and Companies http://www.reportlinker.com/p0203548/Pain-Therapeutics---Drugs-Markets-and-Companies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_MedicationThis ...

Think you're bloated by IBS? It could just be Small Intestinal Bacterial Overgrowth and it's easier to manage
For years Patrick Strudwick, left, was told he had IBS but he soon discovered he actually had SIBO which made him look pregnant.

Forest Beats, Ups View
Forest reported earnings per share of $1.04 in the third quarter of fiscal 2012, beating the Zacks Consensus Estimate of $1.00. Third quarter fiscal 2012 earnings, however, came in below the year-earlier ...

Ironwood Pharmaceuticals Announces 5.25M Stock Offering
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD)  announced tod...

Ask an Expert: Aloe's value, diabetes
Need advice? Health and wellness experts are ready to address your questions. Email health@ tennessean.com or mail to The Tennessean, Ask An Expert, 1100 Broadway, Nashville, TN 37203. Content may be edited for clarity.